|
[1]BJORNSSON E, JERLSTAD P, BERGQVIST A, et al.Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden[J].Scand J Gastroenterol, 2005, 40 (9) :1095-1101.
|
|
[2]OHMORI S, SHIRAKI K, INOUE H, et al.Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure[J].Hepatogastroenterology, 2003, 50 (53) :1531-1534.
|
|
[3]OSTAPOWICZ G, FONTANA RJ, SCHIODT FV, et al.Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States[J].Ann Intern Med, 2002, 137 (12) :947-954.
|
|
[4]REUBEN A, KOCH DG, LEE WM.Drug-induced acute liver failure:Results of a U.S.multicenter, prospective study[J].Hepatology, 2010, 52 (6) :2065-2076.
|
|
[5]RUSSO MW, GALANKO JA, SHRESTHA R, et al.Liver transplantation for acute liver failure from drug induced liver injury in the United States[J].Liver Transpl, 2004, 10 (8) :1018-1023.
|
|
[6]WEI G, BERGQUIST A, BROOME U, et al.Acute liver failure in Sweden:Etiology and outcome[J].J Intern Med, 2007, 262 (3) :393-401.
|
|
[7]BJORNSSON ES, BERGMANN OM, BJORNSSON HK, et al.Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland[J].Gastroenterology, 2013, 144 (7) :1419-1425, 25 e1-e3;quiz e19-e20.
|
|
[8]SGRO C, CLINARD F, OUAZIR K, et al.Incidence of drug-induced hepatic injuries:A French population-based study[J].Hepatology, 2002, 36 (2) :451-455.
|
|
[9] SHEN T, MAO YM, CHEN CW.An epidemiological study of drug-induced liver injury in China[R].The Fourth National Academic Conference on Drug-induced Liver Injury, 2017. (in Chinese) 沈弢, 茅益民, 陈成伟.中国DILI流行病学研究[R].第四届全国药物性肝损伤学术会议, 2017.
|
|
[10]CHENG CY, WANG S, ZHANG YH.37 clinical reports of drug-induced liver diseases[J].Chongqing Med J, 1999, 28 (3) :198-199. (in Chinese) 程朝英, 王莎, 张姚衡.药物性肝损害37例临床分析[J].重庆医学, 1999, 28 (3) :198-199.
|
|
[11]ZHOU HJ, LI SG.103 clinical reports of drug-induced liver diseases[J].Chin J Clin Pharm, 2001, 10 (5) :291-293. (in Chinese) 周华坚, 李韶光.药物性肝损害103例临床分析[J].中国临床药学杂志, 2001, 10 (5) :291-293.
|
|
[12]GUAN YJ, XIAN JZ, TANG XP, et al.Clinical analysis of drug-induced liver disease in 191 patients[J].Chin J Hepatol, 2003, 11 (7) :390. (in Chinese) 关玉娟, 冼建中, 唐小平, 等.191例药物性肝病患者的临床分析[J].中华肝脏病杂志, 2003, 11 (7) :390.
|
|
[13]ZHOU SM, JIA J.Clinical analysis of 96 patients with traditional Chinese medicine-induced liver diseases[J].China Trop Med, 2004, 4 (5) :765-766. (in Chinese) 周世明, 贾杰.中草药致药性肝病96例临床分析[J].中国热带医学, 2004, 4 (5) :765-766.
|
|
[14]SHANG J, XU Y, YANG YX, et al.Preliminary clinical study on drug-induced liver lesions in 104 patients[J].Chin J Hepatol, 2004, 12 (11) :694. (in Chinese) 尚佳, 徐芸, 杨玉秀, 等.药物性肝病104例临床分析[J].中华肝脏病杂志, 2004, 12 (11) :694.
|
|
[15]Cooperative Group of Hepatobiliary Disease of Digestive Disease Branch of Chinese Medical Association.A multicenter survey on hospital inpatients with drug-induced acute liver injury in China[J].Chin J Dig, 2007, 27 (7) :439-442. (in Chinese) 中华医学会消化病学分会肝胆疾病协作组.全国多中心急性药物性肝损伤住院病例调研分析[J].中华消化杂志, 2007, 27 (7) :439-442.
|
|
[16]LI L, JIANG W, WANG JY, et al.Clinical analysis of acute drug-induced liver disease in 275 cases[J].J Clin Hepatol, 2009, 25 (1) :44-46. (in Chinese) 李蕾, 蒋炜, 王吉耀, 等.275例急性药物性肝病临床分析[J].临床肝胆病杂志, 2009, 25 (1) :44-46.
|
|
[17]YNAG LX.Clinical analysis of 248 cases of drug induced liver diseases[J].Chin J Gastroenterol Hepatol, 2012, 21 (3) :261-263. (in Chinese) 杨立新.药物性肝病248例临床分析[J].胃肠病学和肝病学杂志, 2012, 21 (3) :261-263.
|
|
[18] CAI Y.Clinical analysis of 120 cases of drug induced liver diseases[J].China Health Nutrition, 2014, 24 (7) :3764-3765. (in Chinese) 柴颖.药物性肝病120例临床分析[J].中国保健营养, 2014, 24 (7) :3764-3765.
|
|
[19]LAI RT, WANG H, GUI HL, et al.Clinical and pathological features in 138 cases of drug-induced liver injury[J].Chin J Hepatol, 2012, 20 (3) :185-189. (in Chinese) 赖荣陶, 王晖, 桂红莲, 等.138例药物性肝损伤患者的临床特征及肝脏组织学改变[J].中华肝脏病杂志, 2012, 20 (3) :185-189.
|
|
[20]WAI CT.Presentation of drug-induced liver injury in Singapore[J].Singapore Med J, 2006, 47 (2) :116-120.
|
|
[21]ZHOU Y, YANG L, LIAO Z, et al.Epidemiology of drug-induced liver injury in China:A systematic analysis of the Chinese literature including 21, 789 patients[J].Eur J Gastroenterol Hepatol, 2013, 25 (7) :825-829.
|
|
[22]YE DM, LAN S, MENG SY.Drug treatment of drug-induced liver injury:Analysis for 262 cases[J].Eval Anal Drug-Use Hosp China, 2010, 10 (8) :754-757. (in Chinese) 叶冬梅, 兰顺, 蒙石英.262例药源性肝损害病例的药物治疗分析[J].中国医院用药评价与分析, 2010, 10 (8) :754-757.
|
|
[23]WU YS, ZHENG QK, LI YL, et al.A review of drug-induced liver damage in 509 cases[J].ADRJ, 2002, 4 (6) :364-368. (in Chinese) 吴苑珊, 郑企琨, 黎月玲, 等.509例药源性肝损害文献分析[J].药物不良反应杂志, 2002, 4 (6) :364-368.
|
|
[24]WANG M.Chinese medicine induced liver damage[J].Chin J Misdiagn, 2006, 6 (7) :1388-1389. (in Chinese) 王敏.中药致药源性肝损害[J].中国误诊学杂志, 2006, 6 (7) :1388-1389.
|
|
[25]XUE GX.Chinese Medicine clinical review of hepatic lesion[J].Pract Tradit Chin Intern Med, 2010, 24 (8) :81-82. (in Chinese) 薛国新.中药致肝损害的临床回顾[J].实用中医内科杂志, 2010, 24 (8) :81-82.
|
|
[26]LI JJ.Study on hepatotoxicity of traditional Chinese medicine[J].Hubei J Tradit Chin Med, 2012, 34 (8) :73-74. (in Chinese) 李江健.中药肝毒性的探讨[J].湖北中医杂志, 2012, 34 (8) :73-74.
|
|
[27] CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al.ACG Clinical Guideline:The diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966;quiz 67.
|
|
[28]World Health Organization.Global tuberculosis report 2016[R].Geneva, Switzerland:WHO Report 2016.
|
|
[29]ZHAO Y, XU S, WANG L, et al.National survey of drug-resistant tuberculosis in China[J].N Engl J Med, 2012, 366 (23) :2161-2170.
|
DownLoad: